Advertisement
ABOS.OB 外汇新闻
Acumen Pharma Partners Lonza To Advance Sabirnetug For Alzheimer's Disease Treatment
Biopharmaceutical company Acumen Pharmaceuticals, Inc. (ABOS) on Thursday signed a collaboration agreement with Lonza, a global partner to the pharmaceutical, biotech and nutraceutical markets.
RTTNews
|
522天前
